Sorrento Therapeutics Inc

NASDAQ:SRNE   3:59:56 PM EDT
6.81
+0.36 (+5.58%)
Products, Regulatory

Sorrento Announces Updated Positive Results Of Phase 1B Study Of Covi-Msc™ For Treatment Of Icu Covid-19 Patients

Published: 03/25/2021 20:27 GMT
Sorrento Therapeutics Inc (SRNE) - Sorrento Announces Updated Positive Results of Phase 1b Study of Covi-msc™ for Treatment of Icu Covid-19 Patients.
Sorrento Therapeutics Inc - All Nine Patients With Acute Respiratory Failure Due to Covid-19 Discharged.
Sorrento Therapeutics Inc - Preparations Are Ongoing for Initiating Phase 2 Placebo-controlled Study.